United States · FDA National Drug Code directory
KREOSOTE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85816-2227_4ae55c0e-3e9a-703b-e063-6394a90a345a
- Product NDC
- 85816-2227
- Form
- LIQUID
- Composition / generic term
- acid nit, belladonna, borax, chamomilla, kreosote, merc sol, staphysagria
- Labeler
- BM Private Limited
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20150101
- Source listing expiry
- 20271231
Source-listed ingredients
- SODIUM BORATE — 7 [hp_X]/mL
- ATROPA BELLADONNA — 7 [hp_X]/mL
- NITRIC ACID — 7 [hp_X]/mL
- WOOD CREOSOTE — 7 [hp_X]/mL
- MERCURIUS SOLUBILIS — 10 [hp_X]/mL
- CHAMOMILE — 7 [hp_X]/mL
- DELPHINIUM STAPHISAGRIA SEED — 7 [hp_X]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, GLASS (85816-2227-1) · 85816-2227-1
- 500 mL in 1 BOTTLE, GLASS (85816-2227-2) · 85816-2227-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →